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Atrial natriuretic peptide (ANP), via its guanylyl cyclase A (GC-A) recep-
tor and intracellular guanosine 3¢,5¢-cyclic monophosphate production, is
critically involved in the regulation of blood pressure. In patients with
chronic heart failure, the plasma levels of ANP are increased, but the car-
diovascular actions are severely blunted, indicating a receptor or postrecep-
tor defect. Studies on metabolically labelled GC-A-overexpressing cells
have indicated that GC-A is extensively phosphorylated, and that ANP-
induced homologous desensitization of GC-A correlates with receptor
dephosphorylation, a mechanism which might contribute to a loss of func-
tion in vivo. In this study, tandem MS analysis of the GC-A receptor,
expressed in the human embryonic kidney cell line HEK293, revealed
unambiguously that the intracellular domain of the receptor is phosphory-
lated at multiple residues: Ser487, Ser497, Thr500, Ser502, Ser506, Ser510
and Thr513. MS quantiﬁcation based on multiple reaction monitoring dem-
onstrated that ANP-provoked desensitization was accompanied by a com-
plex pattern of receptor phosphorylation and dephosphorylation. The
population of completely phosphorylated GC-A was diminished. However,
intriguingly, the phosphorylation of GC-A at Ser487 was selectively
enhanced after exposure to ANP. The functional relevance of this observa-
tion was analysed by site-directed mutagenesis. The substitution of Ser487
by glutamate (which mimics phosphorylation) blunted the activation of the
GC-A receptor by ANP, but prevented further desensitization. Our data
corroborate previous studies suggesting that the responsiveness of GC-A to
ANP is regulated by phosphorylation. However, in addition to the dephos-
phorylation of the previously postulated sites (Ser497, Thr500, Ser502,
Ser506, Ser510), homologous desensitization seems to involve the phos-
phorylation of GC-A at Ser487, a newly identiﬁed site of phosphorylation.
The identiﬁcation and further characterization of the speciﬁc mechanisms
involved in the downregulation of GC-A responsiveness to ANP may have
important pathophysiological implications.
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Guanylyl cyclase A (GC-A, also known as natriuretic
peptide receptor A) is a transmembrane receptor
which synthesizes the intracellular second messenger
guanosine 3¢,5 ¢-cyclic monophosphate (cGMP) on
binding of the ligands atrial natriuretic peptide (ANP)
and B-type natriuretic peptide (BNP) to its extracellu-
lar domain. The NP⁄GC-A⁄cGMP system has impor-
tant endocrine functions in the maintenance of
arterial blood pressure and volume homeostasis [1].
Mice with global deletion of the genes encoding the
GC-A receptor or ANP show marked hypervolemic
hypertension and cardiac hypertrophy [2–5]. The rele-
vance of these experimental observations to normal
human physiology has been elegantly established by a
recent genetic study which examined the association
of common variants at the ANP and BNP gene loci
with circulating concentrations of ANP⁄BNP and
blood pressure [6]. The results demonstrated that
genetically determined small variations in NP concen-
trations are associated with signiﬁcant changes in
blood pressure [6].
The GC-A receptor consists of an extracellular
ligand-binding domain of approximately 441 amino
acids (aa), a short membrane-spanning region (21 aa)
and an intracellular portion (567 aa), containing a
kinase homology (KH) domain, the dimerization
domain and the C-terminal catalytic GC domain [1,7].
In the absence of ligand, GC-A forms homodimers or
homotetramers, the KH domain is highly phosphory-
lated and the catalytic activity is tightly repressed
[8–10]. On ANP binding, there is no change in the
oligomeric state, but apparently a conformational
change occurs which activates the cyclase domain [11].
Two cyclase domains form an active site and the sec-
ond messenger cGMP is produced [11,12]. cGMP acti-
vates different intracellular signalling cascades which
ultimately mediate the above-mentioned cardiovascular
functions of ANP and BNP. The role of the KH
domain is largely unknown. It presents approximately
30% homology to tyrosine kinases and approximately
20% homology to protein kinase A [13], but kinase
activity has never been demonstrated. In the peptide-
unliganded state, it inhibits the GC domain, a conclu-
sion drawn from the observation that the KH domain
deletion mutant is constitutively active [14]. Binding of
a single peptide ligand between the two extracellular
domains results in their relative reorientation, possibly
relieving the inhibitory effect of the KH domains
[11,15,16]. However, the mechanism by which KH
domains mediate communication between the ligand-
binding and GC domains is unclear.
In all patients with hypertensive cardiac hypertrophy
and heart failure, the plasma levels of ANP and BNP
are markedly increased, but the GC-A receptor-medi-
ated functions are clearly diminished, indicating a
receptor or postreceptor defect [1]. In view of the criti-
cal role of the NP⁄GC-A system in the moderation of
blood pressure and volume [1–6], the identiﬁcation of
the speciﬁc mechanisms involved in the downregula-
tion of GC-A activity may have important pathophysi-
ological and clinical implications. Chronic exposure of
the receptor to high concentrations of ANP can lead
to homologous desensitization, which has been shown
in many in vitro studies [17–20]. This desensitization
procedure is probably a result of post-translational
modiﬁcations, particularly dephosphorylation of the
receptor [20]. Hence, on the basis of metabolic label-
ling experiments with GC-A-overexpressing HEK293
cells (human embryonic kidney cell line), Potter and
Hunter [21,22] suggested the presence of six phosphor-
ylated amino acids within a stretch of 15 membrane-
near residues of the KH domain: Ser497, Thr500,
Ser502, Ser506, Ser510 and Thr513. Mutations of these
residues to Ala, mimicking the dephosphorylated ver-
sion of the receptor, led to a diminished cGMP
response of GC-A to ANP. In contrast, the conversion
of these residues to glutamate, which mimics the nega-
tive charge of the phosphate moiety, restored receptor
activity and ANP responsiveness [22]. From these
experiments, Potter and Hunter [21,22] concluded that
the phosphorylation of the KH domain is absolutely
required for activation by ANP. In turn, dephosphory-
lation results in a desensitized receptor with diminished
responsiveness to further hormonal stimulation. Thus,
in contrast with G-protein-coupled receptors, which
are desensitized by phosphorylation, phosphorylation
seems to sensitize the GC-A receptor to ANP. How-
ever, the protein kinases and phosphatases responsible
for this regulation have not been identiﬁed.
In this study, we aimed to verify unambig-
uously the postulated phosphorylated residues and to
characterize the so far unknown phosphorylated sites
within the GC-A receptor. We enriched and puriﬁed
FLAG-tagged GC-A from stably expressing HEK293
cells, as well as native GC-A from cultured murine
cardiac microvascular endothelial cells, and analysed
the phosphorylated residues by MS. The results con-
ﬁrm the phosphorylation of GC-A at the six amino
acids previously suggested by Potter and Hunter
[21,22], and reveal an additional neighbouring site of
phosphorylation at Ser487. MS quantiﬁcation based
on multiple reaction monitoring was then applied to
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HEK293 cells under basal conditions and after ANP-
provoked homologous desensitization. Intriguingly,
these results suggest that, in addition to the dephos-
phorylation of the previously postulated sites (Ser497,
Thr500, Ser502, Ser506, Ser510 and Thr513), homolo-
gous desensitization of GC-A involves the phosphory-
lation of Ser487. Indeed, the results of site-directed
mutagenesis, together with guanylyl cyclase receptor
activity assays, support a role for the phosphorylation
of this residue in the inhibitory regulation of GC-A
activity.
Results and Discussion
The FLAG epitope does not modify the activity
and subcellular localization of the GC-A receptor
First, it was necessary to prove that the N-terminal
FLAG tag used to enrich GC-A from expressing
HEK293 cells does not inﬂuence the activity of the
receptor, its responsiveness to ANP or the subcellular
localization.
The cGMP responses of HEK293 cells tran-
siently transfected with either wild-type GC-A or
FLAG-tagged GC-A receptor were quantiﬁed by
RIA. ANP (10 pm–100 nm) evoked concentration-
dependent increases in intracellular cGMP content,
and these responses were similar in wild-type GC-A-
and FLAG-tagged GC-A-expressing HEK293 cells
(Fig. 1A). To monitor the kinetics and duration of
cGMP formation by the two receptors in single intact
cells, ﬂuorescence resonance energy transfer (FRET)
was used (Fig. 1B). The FRET biosensor pGES-DE2
responds to cGMP binding with a robust increase in
FRET [23,24]. HEK293 cells coexpressing either wild-
type GC-A or FLAG-tagged GC-A and the biosensor
pGES-DE2 reacted to ANP with a strong increase in
the FRET signal, indicating increases in [cGMP]i.T h e
kinetics, duration and extent of cGMP formation in
response to ANP were similar in wild-type GC-A-
and FLAG-tagged GC-A-expressing HEK293 cells
(Fig. 1B).
The subcellular localization of wild-type and FLAG-
tagged GC-A in HEK293 cells was analysed by immu-
nocytochemistry and confocal imaging. Figure 1C
illustrates that both proteins colocalize with the plasma
membrane-bound Ca
2+-ATPase (PMCA).
Taken together, these data demonstrate that the
FLAG epitope does not interfere with the cGMP
responses of GC-A to ANP or the membrane localiza-
tion, and therefore represents a good tool to facilitate
the afﬁnity puriﬁcation of the receptor.
Cell fractionation and immunoprecipitation lead
to enrichment and puriﬁcation of FLAG-tagged
GC-A
To enrich and purify the GC-A receptor for MS analy-
ses, we used HEK293 cells stably expressing the FLAG-
tagged GC-A receptor. The cells were fractionated and
the membrane fraction was used to enrich the receptor
by immunoprecipitation with anti-FLAG IgG. Western
blot analyses with antibodies against PMCA, as a
marker for the cell membrane, and extracellular signal-
regulated kinase 1⁄2( E R K 1⁄2), as a marker for the cyto-
solic fraction, showed that cell fractionation led to a
good separation of the membrane from the cytosolic
proteins and from cell debris and nuclei (Fig. 2A).
Western blot analyses with antibodies against FLAG
and against the C-terminus of GC-A showed that the
receptor was mainly localized in the membrane fraction
(Fig. 2A). A small amount of GC-A was detected in the
cytosolic fraction, which could be a result of incorrectly
folded protein caused by cellular overexpression.
For each puriﬁcation, the cell membrane fractions
from 15 · 10 cm dishes ( 10
7 cells per dish) were
combined and subjected to immunoprecipitation with
anti-FLAG IgG coupled to agarose beads. Bound
proteins were eluted by the addition of synthetic triple-
FLAG peptide. Western blot analyses (Fig. 2B) and
silver-stained gels (Fig. 2C) demonstrated that this pro-
cedure resulted in a marked enrichment (by approxi-
mately 13-fold; Fig. 2B) and puriﬁcation (Fig. 2C) of
GC-A. The eluted GC-A protein was precipitated by
trichloroacetic acid, separated by SDS⁄PAGE and
visualized by colloidal Coomassie staining (Fig. 2D).
The protein band corresponding to GC-A (MW 
130 kDa) was excised and digested with trypsin.
MS analyses of the GC-A receptor, exogenously
expressed in HEK293 cells, reveal seven
phosphorylated residues within the KH domain
On the basis of experiments with GC-A-over-
expressing HEK293 cells, metabolic labelling with
[
32P]orthophosphate and site-directed mutagenesis,
Potter and Hunter [21,22] described six phosphorylated
residues within the KH domain. Here, we applied MS to
verify unambiguously these postulated sites and to
search for additional phosphorylation sites within the
GC-A receptor without metabolic labelling and there-
fore without stressing the cells [25,26]. Trypsin digestion
and liquid chromatography (LC)-MS⁄MS yielded 61%
sequence coverage of the 130 kDa rat GC-A, with high-
est sequence coverage for the N-terminus (positions
22–200 of the extracellular domain), the KH domain
Phosphorylation of the ANP receptor J. Schro ¨ter et al.
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(Fig. S1). However, in these analyses, we did not detect
phosphopeptides, indicating that they are less abundant
than nonphosphorylated tryptic GC-A peptides.
To enhance the sensitivity of our measurements,
TiO2 afﬁnity chromatography was used to enrich the
putative phosphopeptides. Detection was performed by
nano-LC-MS⁄MS. The combined results of two inde-
pendent biological experiments (two puriﬁcations of
GC-A, four enrichments by TiO2) are summarized in
Table 1, including only phosphopeptides which were
reproducibly detected and manually validated. Further
potential phosphopeptides which did not pass this man-
ual validation are not included. The spectra are shown
in Fig. S2. As depicted in Table 1, all detected tryptic
phosphopeptides were derived from the KH domain of
GC-A, and all six phosphorylation sites previously
deduced by Potter and Hunter [21,22] from experiments
with metabolically labelled HEK293 cells were veriﬁed:
Ser497, Thr500, Ser502, Ser506, Ser510, Thr513
(Fig. 3). In addition, one novel site of phosphorylation
was identiﬁed at Ser487 within the KH domain
(Table 1; Fig. 3). The mass spectra of the two tryptic
peptides (478–490 and 480–490 of GC-A) containing
this new phosphorylation site are shown in Fig. 4.
As depicted in Table 1, in these experiments, both
fully and partially phosphorylated tryptic peptides
were detected. For instance, the tryptic peptide SAG-
SRLTLSGR (residues 494–504) can be phosphorylated
at three sites (Ser497, Thr500 and Ser502). Only one of
the three possible single phosphorylated peptides
(phosphorylated at Ser497) was detected (Table 1).
When this peptide is phosphorylated at Ser497,
upstream tryptic cleavage is considerably reduced at
Arg498 (SAGSR | LTLSGR) because of steric hin-
drance by the phosphate. This might explain why the
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Fig. 1. The N-terminal FLAG epitope does
not alter the activity and subcellular localiza-
tion of the GC-A receptor. (A) HEK293 cells
expressing either the wild-type (wt) GC-A or
FLAG-tagged GC-A receptor were incubated
with ANP (10 pM to 100 nM, 10 min).
Intracellular cGMP contents were quantiﬁed
by RIA. Inset in (A): western blot analysis
demonstrated similar expression levels of
wt and FLAG-tagged GC-A. (B) FRET was
used to monitor the kinetics and extent of
cGMP formation in single HEK293 cells
cotransfected with either wt GC-A or
FLAG-tagged GC-A and cGMP indicator
(pGES-DE2 [24]). Left: FRET images of two
cells prior to and during incubation with
ANP: wt GC-A with vehicle (a) and 10 nM
ANP (b); FLAG-tagged GC-A with vehicle
(c) and ANP (d). Right: representative
ratiometric recordings of single-cell FRET
signals. (C) Confocal immunoﬂuorescence
images of HEK293 cells transfected with wt
or FLAG-tagged GC-A demonstrate the
colocalization with PMCA.
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even by multiple reaction monitoring. When not phos-
phorylated at Ser497, the peptide SAGSRLTLSGR
can be cleaved by trypsin, and therefore the other two
phosphorylation sites (Thr500 and Ser502) were
detected in the peptides LpTLSGR and LTLpSGR. The
triply phosphorylated peptide SAGpSRLpTLpSGR
was also detected. When this peptide is phosphorylated
-250 kDa
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Fig. 2. Enrichment and puriﬁcation of the
FLAG-tagged GC-A receptor from stably
expressing HEK293 cells. (A) Cell fraction-
ation and western blot analyses demon-
strated that FLAG-tagged GC-A is
predominantly localized in the plasma
membrane of HEK293 cells. ERK1⁄2 and
PMCA were used as markers for the
cytosolic and membrane fractions,
respectively. GC-A was detected with
anti-GC-A serum and anti-FLAG IgG.
(B) Western blot analysis demonstrated that
immunoprecipitation of FLAG-tagged GC-A
from the cell membrane fraction led to a
13-fold enrichment of the protein (2 lg
protein per lane). (C) The silver-stained gel
illustrates the step-wise puriﬁcation of the
receptor (10 lg protein per lane). (D) The
immunoprecipitated GC-A protein was
separated by SDS⁄PAGE. After Coomassie
staining, the protein band at 130 kDa was
excised and subjected to in-gel digestion
with trypsin.
Table 1. Rat GC-A (Sprot accession number P18910) tryptic phosphopeptides detected by MS after puriﬁcation of FLAG-tagged GC-A from
overexpressing HEK293 cells. The phosphorylation sites are marked in bold and listed separately. The numbers refer to the respective posi-
tions within the mature GC-A protein [7]. The abbrevations used are as follows: z, precursor charge; m⁄z, mass-to-charge ratio; Mr(exp),
experimental mass; Mr(calc), theoretical mass; Delta, mass deviance Mr(exp) – Mr(calc); ND, not detected.
Position Peptide sequence Phosphorylation site(s) Score m⁄zz M r(exp) Mr(calc) Delta Mass analyser
478–490 R.VRWEDLQPSpSLER.H S487 37 565.66 3 1693.96 1693.78 0.18 QstarElite
480–490 R.WEDLQPSpSLER.H S487 39 720.40 2 1438.72 1438.61 0.11 QstarElite
494–504 R.SAGpSRLTLSGR.G Ser497 33 395.54 3 1183.60 1183.57 0.03 Qtrap
494–504 R.SAGSRLpTLSGR.G ND
494–504 R.SAGSRLTLpSGR.G ND
494–504 R.SAGpSRLpTLSGR.G Ser497 and Thr500 21 422.19 3 1263.54 1263.55 )0.01 Qtrap
494–504 R.SAGpSRLTLpSGR.G Ser497 and Ser502 34 632.83 2 1263.64 1263.54 0.10 QstarElite
494–504 R.SAGSRLpTLpSGR.G Thr500 and Ser502 38 422.21 3 1263.61 1263.54 0.07 Qtrap
494–504 R.SAGpSRLpTLpSGR.G Ser497, Thr500 and Ser502 32 672.71 2 1343.41 1343.50 )0.09 Qtrap
499–504 R.LpTLSGR.G Thr500 34 363.68 2 725.34 725.35 )0.01 Qtrap
499–504 R.LTLpSGR.G Ser502 28 363.68 2 725.33 725.35 )0.02 Qtrap
499–504 R.LpTLpSGR.G Thr500 and Ser502 26 403.69 2 805.37 805.31 0.06 QstarElite
505–523 R.GpSNYGSLLTTEGQFQVFAK.T Ser506 84 1063.89 2 2125.77 2125.97 )0.20 Qtrap
505–523 R.GSNYGpSLLTTEGQFQVFAK.T Ser510 100 1063.91 2 2125.81 2125.97 )0.16 Qtrap
505–523 R.GSNYGSLLpTTEGQFQVFAK.T Thr513 57 709.74 3 2126.20 2125.97 0.23 QstarElite
505–523 R.GpSNYGpSLLTTEGQFQVFAK.T Ser506 and Ser510 78 1103.92 2 2205.83 2205.94 )0.11 Qtrap
505–523 R.GpSNYGSLLpTTEGQFQVFAK.T ND
505–523 R.GSNYGpSLLpTTEGQFQVFAK.T Ser510 and Thr513 87 736.29 3 2205.84 2205.94 )0.10 Qtrap
505–523 R.GpSNYGpSLLpTTEGQFQVFAK.T ND
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is also reduced. Taken together, these results clearly
demonstrate the phosphorylation of GC-A at Ser497,
Thr500 and Ser502 (Table 1).
The tryptic peptide GSNYGSLLTTEGQFQVFAK
(residues 505–523) containing the three additional
phosphorylation sites suggested by Potter and Hunter
[21,22] (Ser506, Ser510 and Thr513) was detected as a
singly and dually phosphorylated form (Table 1); how-
ever, the fully phosphorylated peptide was not
detected. This may be a result of a combination of
reduced suitability of TiO2 enrichment for multiply
phosphorylated peptides and the generally lower ioni-
zation⁄detection properties of highly phosphorylated
peptides in ESI-MS⁄MS. Here, perhaps the use of
alternative enrichment strategies, such as immobilized
metal ion afﬁnity chromatography, in conjunction with
electron transfer dissociation for fragmentation, might
enable the detection.
Lastly, in addition to the tryptic phosphopeptides
containing the previously postulated sites [21,22], we
detected two additional phosphopeptides (residues
478–490 and 480–490), revealing a so far unknown
phosphorylation at the neighbouring Ser487 (Table 1).
The corresponding mass spectra are illustrated in
Figs 4 and S2.
MS analyses of the GC-A receptor, endogenously
expressed in endothelial cells, conﬁrm the newly
identiﬁed site of phosphorylation at Ser487
Next, we analysed the phosphorylation pattern of the
native GC-A receptor endogenously expressed in cul-
tured murine microvascular myocardial endothelial
cells [27]. We used these cells because, compared with
other cell culture systems, they have comparatively
high endogenous GC-A expression levels, and because
ANP modulates important cellular functions, such as
permeability and angiogenic growth (J. Schro ¨ ter et al.,
unpublished observations). Western blot analyses
showed that their GC-A expression levels were approx-
imately 100-fold lower than those of stably transfected
HEK293 cells (not shown). Native GC-A was enriched
from plasma membrane fractions with an antibody
directed against the C-term of the receptor. Similar to
the experiments with HEK293 cells, we detected vari-
ous overlapping tryptic GC-A phosphopeptides derived
from the N-terminus of the KH domain. The tandem
mass spectra, which are illustrated in Fig. S3, revealed
the following phosphorylated residues: Ser 487, Ser497
and Thr500. Because of the low abundance of tryptic
GC-A phosphopeptides, we could not conﬁrm the
additional four phosphorylation sites which were iden-
...QPSS487LERHLRSAGS497RLT500LS502GRGS506NYGS510LLT513TE...
Membrane spanning region
Kinase homology domain
Hinge region
Guanylyl cyclase domain
cGMP GTP
Ligand binding domain
Fig. 3. Scheme illustrating the domains of GC-A and the positions
of the phosphorylated amino acids (in bold). The numbers within
the sequence depict the positions of these amino acids within
mature rat GC-A [7].
Fig. 4. Fragment ion spectra of the phosphopeptides
VRWEDLQPSpSLER and WEDLQPSpSLER, both representing the
phosphorylated Ser487 of the GC-A receptor.
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Ser506, Ser510, Thr513). However, these analyses dem-
onstrate, for the ﬁrst time, the phosphorylation of the
endogenous (untransfected) native GC-A receptor.
Most importantly, they conﬁrm the newly identiﬁed
site of phosphorylation at Ser487.
Multiple reaction monitoring reveals that
homologous desensitization of the GC-A receptor
in HEK293 cells is associated with a complex
phosphorylation pattern
The second part of our study aimed to analyse, in
HEK293 cells, the changes in the phosphorylation pat-
tern of GC-A accompanying its homologous desensiti-
zation. Within each experiment, GC-A-expressing
HEK293 cells were incubated with ANP (100 nm,1h )
or remained untreated (15 dishes per condition; three
independent experiments). For semiquantitative analy-
ses of tryptic GC-A phosphopeptides enriched from
ANP-treated relative to untreated cells, the technique
of multiple reaction monitoring was applied. This
allows a label-free quantiﬁcation of phosphorylated
tryptic GC-A peptides by peak area comparison
[28,29]. After immunoprecipitation and trypsin diges-
tion, the samples were spiked with two synthetic phos-
phopeptides before TiO2 enrichment, and with two
additional synthetic peptides before MS. As shown in
Table 2, within each experiment, the recovery of these
standard peptides from untreated and ANP-treated
samples was nearly identical, ensuring comparability.
Table 2 summarizes the results of three independent
biological experiments (mean values ± SEM of eight
independent enrichments, eight analyses by multiple
reaction monitoring). The results are presented as the
ratio of multiple reaction monitoring peak areas for
tryptic GC-A phosphopeptides detected after puriﬁca-
tion of the FLAG-tagged GC-A receptor from
HEK293 cells either pretreated with ANP (100 nm,
1 h) or untreated (controls). In each experiment, both
conditions (±ANP) were compared. Western blot
results demonstrated that the amount of GC-A in cells
did not change signiﬁcantly after 1 h of ANP stimula-
tion (Fig. 6B). However, as described in the next sec-
tion, ANP pretreatment markedly reduced the
responsiveness of GC-A to subsequent ANP stimula-
tion, indicating homologous desensitization of the
receptor. Figure 5 illustrates four examples of multiple
reaction monitoring scans showing considerable
changes in peptide abundance on ANP treatment. For
instance, the sum of the peak areas of the four transi-
tions of the peptide WEDLQPSpSLER, which con-
tains the newly discovered phosphorylation site Ser487,
on average was increased by approximately nine-fold
in ANP-treated samples, indicating an increased
amount of peptide (Fig. 5). Taken together, the results
from multiple reaction monitoring revealed that the
amount of partially phosphorylated tryptic peptides
containing the residues Ser497, Thr500 and Ser502 was
increased by approximately two-fold after ANP pre-
treatment (Table 2). In contrast, the amount of com-
pletely phosphorylated peptides was decreased by 50%
or more (Table 2, asterisks). These observations indi-
cate that homologous desensitization of GC-A was
concomitant with a reduction in the population of
GC-A receptors fully phosphorylated at positions
Ser497, Thr500 and Ser502. This is in line with the
observations of Potter et al. [21,22,30] in metabolically
labelled HEK293 cells, which showed a marked
dephosphorylation of GC-A after ANP pretreatment.
Our present results extend these observations, suggest-
ing that the cGMP responses of GC-A to ANP are
already blunted when the receptor population is not
totally, but only partly, dephosphorylated.
Unfortunately, the results obtained for the tryptic
phosphopeptide spanning positions 505–523 of GC-A,
which contains the phosphorylation sites Ser506,
Ser510 and Thr513, are difﬁcult to interpret, because,
as mentioned above, the fully phosphorylated version
was never detected. Nevertheless, Table 2 demonstrates
that the relative amount of partially phosphorylated
peptides was increased in samples obtained from ANP-
treated HEK293 cells (when compared with untreated
cells), again suggesting that the population of receptors
fully phosphorylated at these three additional positions
was diminished.
Most remarkably, as already mentioned above, the
amount of the two tryptic GC-A phosphopeptides con-
taining the newly detected phosphorylation at Ser487
was strongly increased after ANP pretreatment, by
nearly nine-fold (Table 2, top). This suggests that this
phosphorylation site, in contrast with the others, is
phosphorylated during homologous desensitization.
Hence, homologous desensitization of GC-A is associ-
ated with a complex pattern of (de)phosphorylation of
the receptor, with a selective prominent increase in the
phosphorylation of GC-A at Ser487.
Site-directed mutagenesis indicates that
phosphorylation of the GC-A receptor at Ser487
inhibits its activity
To analyse whether the phosphorylation of Ser487
modulates the responsiveness of GC-A to ANP, this
residue was substituted with glutamate (S487E) to
mimic constitutive phosphorylation by substituting
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charged side-chain. The effect of this substitution on
GC-A activity was evaluated in guanylyl cyclase assays
performed with crude membranes from GC-A-express-
ing HEK293 cells. The membranes were incubated
with ANP, and cGMP formation was measured by
RIA. We conﬁrmed, by immunoblotting, that mutant
and wild-type GC-A receptors were expressed in simi-
lar amounts (see insets in Fig. 6A,B). In addition, to
account for small differences in the expression level of
the two variants, we normalized the basal and ANP-
stimulated activity data with the respective maximal,
Triton-stimulated, GC-A activity [12,17,21,22].
Wild-type GC-A responded to ANP with concentra-
tion-dependent increases in cGMP production
(Fig. 6A). In comparison, the cGMP responses of the
mutant GC-A S487E to ANP were markedly blunted
(Fig. 6A). One possible explanation for this reduced
responsiveness is the different steric conformation of
glutamate and phosphate, which might impose differ-
ent constraints on protein conformation. However, it
should be noted that, in previous studies, mutations of
the other phosphorylated residues (Ser497, Thr500,
Ser502, Ser506, Ser510 and Thr513) to glutamate did
not reduce, but enhanced, receptor activity and respon-
siveness, indicating that glutamate adequately mim-
icked the phosphorylated state [21,22]. Taken together,
our observations showing that the cGMP responses of
GC-A S487E to ANP were markedly impaired, and
that ANP-induced desensitization of GC-A was
accompanied by greatly increased phosphorylation at
Ser487, support a role for the phosphorylation of this
residue in the inhibitory regulation of GC-A activity.
To follow this hypothesis, we tested the inﬂuence of
the substitution of Ser487 with glutamate on the pro-
cess of homologous desensitization of GC-A. HEK293
cells expressing wild-type GC-A or GC-A S487E were
incubated with ANP (100 nm, 1 h) or remained
untreated. After vigorous washing, cell membranes
were prepared for the assay of guanylyl cyclase activity.
As shown in Fig. 6B, ANP pretreatment markedly
diminished the cGMP responses of wild-type GC-A to
a subsequent stimulation with 10 nm ANP. Notably,
western blotting demonstrated that ANP pretreatment
Table 2. Relative quantiﬁcation of the phosphorylated tryptic peptides by multiple reaction monitoring. The ratio of multiple reaction monitor-
ing peak areas after ANP pretreatment versus control conditions was calculated. Shown are the mean values ± SEM of the ratios obtained
in three independent biological experiments (in total eight enrichments, eight analyses with multiple reaction monitoring). The fully phosphor-
ylated tryptic peptides are marked by an asterisk. Standard synthetic (phospho)peptides were added to the samples as described.
Ratios of signal intensities of phospho-
peptides obtained from ANP-pretreat-
ed versus untreated HEK293 cells
Phosphopeptides Phosphorylation site(s) Mean SEM
WEDLQPSpSLER Ser487 9.55 1.31
VRWEDLQPSpSLER Ser487 9.72 1.58
LTLpSGR Ser502 2.30 0.37
LpTLSGR Thr500 1.79 0.23
LpTLpSGR* Thr500 and Ser502 0.50 0.09
SAGpSRLTLSGR Ser497 0.94 0.31
SAGSRLpTLpSGR Thr500 and Ser502 3.64 0.99
SAGpSRLTLpSGR Ser497 and Ser502 2.60 0.48
SAGpSRLpTLSGR Ser497 and Thr500 2.63 0.44
SAGpSRLpTLpSGR* Ser497, Thr500 and Ser502 0.19 0.07
GSNYGpSLLTTEGQFQVFAK Ser510 1.61 0.36
GpSNYGSLLTTEGQFQVFAK Ser506 2.51 0.68
GSNYGSLLpTTEGQFQVFAK Thr513 1.72 0.39
GpSNYGpSLLTTEGQFQVFAK Ser506 and Ser510 0.94 0.29
GSNYGpSLLpTTEGQFQVFAK Ser510 and Thr513 1.25 0.76
Synthetic standard peptides
VGGHAAEYGAEALER 0.93 0.09
TEREDLIAYLK 0.94 0.10
VKVDEVGGEALGR 1.07 0.05
EFTPVLQADFQK 0.98 0.04
Synthetic standard phosphopeptides
DIGpSEpSTEDQAEDIK Ser4 and Ser6 1.22 0.34
NSLVTQDDpTFKDK Thr9 1.07 0.07
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in Fig. 6B). Hence, in agreement with previous studies
[22,30], this experimental condition led to a pronounced
homologous desensitization of the GC-A receptor,
which was not caused by receptor internalization or
degradation. Once more, the experiments with HEK293
cells expressing GC-A S487E led to a completely differ-
ent result. As mentioned above, already under basal
conditions (without ANP pretreatment), the responsive-
ness of this mutated receptor to ANP was markedly
blunted. In fact, the cGMP responses of GC-A S487E
to 10 nm ANP were similar to the responses of the
desensitized wild-type GC-A receptor (Fig. 6B). In
addition, GC-A S487E was not further inactivated by
ANP pretreatment (Fig 6B). These observations cor-
roborate our hypothesis that the phosphorylation at
Ser487 could be involved in the desensitization of the
receptor. We propose that ANP-induced phosphoryla-
tion of Ser487 either directly induces a conformational
change which inhibits GC-A activity or creates a dock-
ing site for a phosphatase which catalyses the dephos-
phorylation of the neighbouring residues.
In summary, our study demonstrates, for the ﬁrst
time, the phosphorylation pattern of the GC-A recep-
tor in overexpressing HEK293 cells by MS. Seven
phosphorylated amino acids within the KH domain
were unambiguously detected: Ser497, Thr500, Ser502,
Ser506, Ser510 and Thr513 (which were previously
indicated by Potter et al. [21,22,30]), and a novel site
of phosphorylation at the neighbouring proximal
Ser487. Several of these phosphorylation sites (Ser487,
Ser497 and Thr500) were veriﬁed in murine microvas-
cular endothelial cells endogenously expressing the
GC-A receptor. Remarkably, these studies conﬁrmed
the newly identiﬁed site of phosphorylation of native,
endogenous GC-A at Ser487. In HEK293 cells, homo-
logous desensitization of GC-A was accompanied by a
diminished population of completely phosphorylated
GC-A receptors, but a selective and dramatic increase
in the phosphorylation at Ser487. Lastly, a functional
role for phosphorylation at Ser487 in the ANP-
induced inactivation of GC-A has been demonstrated
by engineering a mutation that mimics the phosphory-
lated form of this residue. Application of the kinase–
substrate interaction prediction algorithms NetphosK
and NetworKIN validated our MS results, revealing a
high probability of phosphorylation of GC-A at
Ser487. These computational analyses indicated that
this site conforms to the consensus motifs for the
DNA-dependent protein kinase catalytic subunit and
for cyclin-dependent kinase 2. The DNA-dependent
protein kinase catalytic subunit plays an important
role in the repair of DNA double-strand breaks. The
mitotic cyclin-dependent kinase 2 is involved in the
regulation of progression through the cell cycle. Noth-
ing is known about the role of these kinases in the
control of arterial blood pressure, and therefore both
are unlikely to participate in the regulation of the
responsiveness of the GC-A receptor to ANP. Hence,
although the critical role of phosphorylation in the
regulation of GC-A enzymatic activity and responsive-
ness to ANP has been clearly demonstrated by the
present and published studies [21,22,30], the protein
kinases and phosphatases that add phosphate to and
remove it from the receptor have yet to be identiﬁed.
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Fig. 5. Multiple reaction monitoring was used for semiquantitative
analysis of the tryptic GC-A phosphopeptides obtained from ANP-
relative to vehicle-treated (control) FLAG-tagged GC-A-expressing
HEK293 cells. Four transitions obtained from MS⁄MS spectra of
the phosphopeptide WEDLQPSpSLER were chosen to analyse the
peptide content in ANP-treated relative to untreated samples. Peak
areas, which are depicted under the spectra, showed an approxi-
mately nine-fold increase in ANP-treated versus untreated samples,
indicating an increase in peptide amount (sum of peak areas with-
out pretreatment, 352 000; sum of peak areas after ANP
pretreatment, 3 140 000). (A) Transition 720.3⁄486.3. (B) Transition
720.3⁄670.4. (C) Transition 720.3⁄768.4. (D) Transition
720.3⁄288.1.
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we will attempt to generate phosphospeciﬁc antibodies
to further characterize the modulation and function of
pGC-A Ser487 and the (patho)physiological relevance
in vivo.
One important limitation to our study was the low
abundance of phosphorylated tryptic peptides in con-
trast with unphosphorylated peptides, which made it
difﬁcult to detect the phosphorylation sites. This limi-
tation was partly solved by using TiO2 afﬁnity chroma-
tography. In addition, although the whole receptor
was scanned by MS, the results obtained with GC-A
puriﬁed from overexpressing HEK293 cells only pro-
vided 61% coverage of the protein sequence (Fig. S1).
As a result of this limitation, we cannot rule out the
existence of additional phosphorylation sites within the
GC-A receptor, which, for instance, might not be sui-
ted to tryptic digestion, or which might reveal poor
fragmentation on collision-induced dissociation. In
view of the important cardiovascular actions of the
ANP⁄GC-A system, the identiﬁcation and further
characterization of the post-translational modiﬁcations
and of the regulatory proteins involved in the downre-
gulation of GC-A activity may have important patho-
physiological implications. We hope that the methods
and observations described in this article will be help-
ful in facilitating some of these discoveries.
Experimental procedures
Determination of intracellular cGMP by RIA
and FRET
HEK293 cells were maintained in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 10% fetal bovine
serum. The cells were transiently transfected with the plas-
mids pCMV5-GC-A (encoding wild-type rat GC-A cDNA)
or pCMV5-FLAG-GC-A (encoding N-terminally FLAG-
tagged rat GC-A) using FuGene transfection reagent,
according to the manufacturer’s recommendations (Roche
Applied Science, Mannheim, Germany). One day later, the
cells were serum starved for 16 h and then stimulated with
ANP (rat ANP; Bachem, Heidelberg, Germany) for 10 min
in the presence of the phosphodiesterase inhibitor 3-isobu-
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Fig. 6. The impact of the phosphorylation of the GC-A receptor at Ser487 on the responsiveness and homologous desensitization of the
receptor was characterized by site-directed mutagenesis followed by guanylyl cyclase activity assays. Crude membranes prepared from
HEK293 cells expressing wild-type (wt) GC-A or GC-A S487E were incubated with vehicle, ANP or detergent (Triton X-100). cGMP produc-
tion was measured by RIA [fmol cGMPÆ(lg protein)
)1Æmin
)1]. All values were calculated as X-fold of the maximal (Triton X-100-induced) activ-
ity (means ± SEM). The western blots shown in the insets demonstrate similar expression levels of wt and mutated GC-A (all 10 lg protein
per lane). (A) ANP evoked concentration-dependent increases in GC-A activity. The GC-A S487E mutant showed signiﬁcantly reduced
responsiveness to ANP (n = 9 from three independent experiments). (B) HEK293 cells were pretreated with ANP (100 nM, 1 h) or vehicle
before the preparation of cell membranes. ANP pretreatment decreased signiﬁcantly the cGMP response of wt GC-A to subsequent stimula-
tion with 10 nM ANP, indicating homologous desensitization. The GC-A S487E mutant showed a signiﬁcantly diminished cGMP response to
10 nM ANP, which was not further inhibited by ANP pretreatment (n = 6 from three independent experiments).
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Germany). Intracellular cGMP was measured by RIA [23].
In addition, FRET was used to monitor, in real time, the
kinetics and extent of cGMP formation in intact HEK293
cells cotransfected with wild-type or FLAG-tagged GC-A
and the cGMP indicator pGES-DE2 [23,24].
Fluorescence microscopy
HEK293 cells, stably expressing wild-type GC-A or FLAG-
tagged GC-A receptors, were grown in chamber slides, ﬁxed
in ice-cold 4% paraformaldehyde, permeabilized with 0.2%
Triton X-100 and blocked with 5% fetal bovine serum in
phosphate-buffered saline solution (NaCl⁄Pi). After incuba-
tion with primary antibodies against GC-A (generated in
our laboratory against the C-terminus of GC-A,
CKGKVRTYWLLGERGSSTRG), FLAG (Sigma-Aldrich)
or PMCA (clone 5F10, Sigma-Aldrich), the cells were incu-
bated with ﬂuorescence-conjugated secondary antibodies.
Enrichment of FLAG-tagged GC-A receptor by
cell fractionation and immunoprecipitation
HEK293 cells, stably expressing FLAG-tagged GC-A, were
cultivated in Dulbecco’s modiﬁed Eagle’s medium supple-
mented with 10% fetal bovine serum and zeocin
(300 lgÆmL
)1). For separation of the soluble and particu-
late cellular proteins, 15 dishes (10 cm) ( 15 · 10
7 cells)
were washed twice with NaCl⁄Pi and lysed on ice to sepa-
rate the cytosol according to the manufacturer’s instruc-
tions (CF-Cyt, NanoTools, Teningen, Germany). After
centrifugation at 1000 g for 5 min at 4  C, the supernatant
containing the cytosolic fraction was removed. The mem-
brane pellet was lysed in Tris buffer of the following com-
position: 20 mm Tris⁄HCl, pH 7.4, 150 mm NaCl, 1 mm
Na2EDTA, 1 mm EGTA, 1.5 mm Na2H2P2O7 and 1%
Triton X-100, supplemented with protease and phosphatase
inhibitor cocktails (Roche Applied Science). The latter
contains sodium orthovanadate, sodium pyrophosphate,
among others, and inhibits the classes of acid and alkaline
phosphatases, as well as serine⁄threonine (PP1, PP2A,
PP2B) and tyrosine protein phosphatases. Because it was
shown in experiments with metabolically labelled HEK293
cells that this combination inhibits the dephosphorylation
of GC-A [22,30], these phosphatase inhibitors were also
included in all subsequent puriﬁcations. After incubation
with lysis buffer for 30 min on ice with vigorous vortexing,
the cell debris and nuclei were pelleted by centrifugation at
2000 g for 10 min at 4  C. The resulting supernatant
contained the solubilized cell membranes.
FLAG-tagged GC-A receptor was enriched from mem-
brane fractions by incubation with anti-FLAG IgG coupled
to agarose beads (M2 agarose, Sigma-Aldrich) for 2 h at
4  C, followed by extensive washing with Tris buffer. The
protein was eluted in Tris buffer containing 600 lgÆmL
)1
synthetic triple FLAG peptide (Sigma-Aldrich). The protein
concentration was determined by the bicinchoninic acid
protein assay (Interchim, Mannheim, Germany).
Western blot analyses and silver staining
Aliquots of the extracted and immunoprecipitated proteins
were incubated with Laemmli buffer and separated by
SDS⁄PAGE. For western blotting, antibodies were against
PMCA, the mitogen-activated protein kinase ERK1⁄2 (Cell
Signaling Technology, Frankfurt, Germany), FLAG or
GC-A. Immunoreactive proteins were detected by chemilu-
minescence using ECL (Thermo Scientiﬁc, Schwerte,
Germany). SDS⁄PAGE and silver staining were used to
assess the purity of the fractions.
Preparation of samples for TiO2 afﬁnity
chromatography
For MS, the immunoprecipitated FLAG-tagged GC-A
receptor was puriﬁed by SDS⁄PAGE (8% gel), stained with
Coomassie, and the GC-A band (apparent MW  130 kDa)
was excised from the gel. In-gel digestion with trypsin (Pro-
mega, Mannheim, Germany) was conducted according to
Wilm et al. [31]. After elution of the tryptic peptides, phos-
phorylated peptides were further enriched by TiO2 afﬁnity
chromatography. The peptide eluate was concentrated under
vacuum and the nearly dried peptides were incubated in
loading buffer (80% acetonitrile, 2.5% triﬂuoroacetic acid,
saturated with phthalic acid) containing 200 lg of TiO2
beads per excised protein band for 1 h at room temperature.
The beads were washed twice with loading buffer, washing
buffer (80% acetonitrile, 0.1% triﬂuoroacetic acid) and
0.1% triﬂuoroacetic acid, and the phosphopeptides were
eluted in three steps with 200, 300 and 400 mm NH4OH
containing 30% acetonitrile. The eluted peptide solution
was immediately acidiﬁed with formic acid to pH 4.0.
Mass spectrometry
Nano-LC-MS⁄MS analyses were carried out using Qtrap 
4000 and QstarElite mass analysers (Applied Biosystems,
Darmstadt, Germany) coupled to Ultimate 3000 nano-
HPLC systems (Dionex, Amsterdam, the Netherlands). The
peptides were concentrated and separated as described pre-
viously [32]. Full MS scans from 350 to 2000 m⁄z were
acquired, and the four (Qtrap  4000) or three (Qstar
  XL)
most intensive signals were subjected to MS⁄MS, taking
into account a dynamic exclusion. Transformation of raw
data into mfg format was performed as described previ-
ously [28]. Tandem mass spectra were searched against the
Swiss-Prot database (June 2009, 497 293 entries) using
Mascot 2.2.0.0. The following search parameters were used:
taxonomy was set to Rattus norvegicus (7419 sequences);
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sites; carbamidomethylation of Cys (+57.02 Da) as ﬁxed
modiﬁcation; oxidation of Met (+15.99 Da) and phosphor-
ylation of Ser⁄Thr⁄Tyr (+79.96 Da) as variable modiﬁca-
tions. For the QTrap, mass tolerances were set to 0.4 Da
for MS and MS⁄MS, whereas, for the QstarElite, mass tol-
erances were set to 0.25 Da for MS and 0.5 Da for
MS⁄MS. Only phosphopeptides with a probability of
P < 0.05 for a random hit were considered and, further-
more, manually validated as described previously [28].
Enrichment of the GC-A receptor from murine
microvascular myocardial endothelial cells
Murine myocardial endothelial cells were maintained in
Dulbecco’s modiﬁed Eagle’s medium with 10% fetal bovine
serum [27]. For overnight starvation, the medium was
reduced to 1% fetal bovine serum. Forty-ﬁve 10 cm dishes
(45 · 10
7 cells) were used for the separation of cytosolic,
plasma membrane and nuclear fractions, as described
above. Endogenously expressed GC-A was enriched by
incubation of the combined plasma membrane fractions
with afﬁnity-puriﬁed anti-GC-A serum (generated in our
laboratory) coupled to agarose beads (Sigma-Aldrich) for
4 h at 4  C, followed by extensive washing with Tris buffer
(see above). The protein was eluted by pH shift (to pH 2.5)
and the acidic eluate was immediately neutralized to pH 7.4
using 0.5 m Tris, pH 9.0, with 1.5 m NaCl. Gel puriﬁcation
by electrophoresis on 8% SDS⁄PAGE, in-gel digest with
trypsin, TiO2 afﬁnity chromatography and nano-LC-
MS⁄MS analyses were carried out as described above,
except that taxonomy was set to Mus musculus.
Multiple reaction monitoring
To characterize the changes in the phosphorylation pattern
of the GC-A receptor exogenously expressed in HEK293
cells after ANP-provoked homologous desensitization, the
tryptic phosphopeptides were quantiﬁed by multiple reaction
monitoring [29]. Appropriate transitions for multiple reac-
tion monitoring were manually selected from representative
fragment ion spectra of the respective phosphopeptides from
previous MS⁄MS analyses. To improve the level of conﬁ-
dence, three to ﬁve fragments per parent ion were selected.
Collision energies were assigned as described previously [33].
A total of 68 multiple reaction monitoring transitions were
used and, for all monitored transitions, the dwell time was
set to 20 ms, whereas the total cycle time was not allowed to
exceed approximately 1 s for a single analysis [33].
For these analyses, HEK293 cells stably expressing
FLAG-tagged GC-A receptor were serum starved for 16 h
and were then incubated with ANP (0.1 lm, 1 h, 37  C) or
remained untreated (in each experiment, 15 · 10 cm dishes
were used for each condition; three independent experi-
ments). Immunoprecipitation of GC-A, in-gel digest with
trypsin, TiO2 afﬁnity chromatography and nano-LC-
MS⁄MS analyses were carried out as described above. Data
interpretation and quantiﬁcation were accomplished using
multiquant 1.0 software (Applied Biosystems) [33]. Esti-
mates of the relative abundance of phosphorylated tryptic
peptides of GC-A isolated from HEK293 cells treated with
ANP relative to untreated cells were determined from the
peak areas of the multiple reaction monitoring scans. Data
are presented as the ratios of the multiple reaction monitor-
ing peak areas of the phosphorylated tryptic GC-A peptides
obtained from ANP-pretreated to untreated HEK293 cells.
The samples were spiked with two synthetic standard phos-
phopeptides before TiO2 afﬁnity chromatography and with
two additional synthetic peptides shortly before starting the
MS analyses (Table 2). The multiple reaction monitoring
scans of these standard peptides were used to ensure that
TiO2 enrichment and MS conditions were equal for tryptic
GC-A phosphopeptides obtained from untreated and ANP-
treated cells.
Site-directed mutagenesis and guanylyl cyclase
assay
Rat FLAG-tagged GC-A in pCMV5 vector served as
template for the site-directed substitution of the novel
phosphorylation site Ser487 with glutamate. The oligonucl-
otide primers and details of PCRs are depicted in Table S1.
The mutation and absence of unwanted mutations were
veriﬁed by sequencing. HEK293 cells were transiently trans-
fected with the wild-type or GC-A S487E expression con-
structs using FuGene (Roche Applied Science). Transfected
cells were serum starved for 16 h prior to ANP (100 nm,
1 h) or vehicle (NaCl⁄Pi) exposure (48 h after transfection).
To prepare crude membranes, the cells of one 10 cm dish
(10
7 cells) were washed twice with NaCl⁄Pi, lysed in Hepes
buffer [50 mm Hepes, pH 7.4, containing 100 mm NaCl,
10% glycerol, protease and phosphatase inhibitor cocktails
(Roche Applied Science)], and the lysates were pelleted by
centrifugation (16 000 g, 10 min, 4  C). The protein concen-
tration was determined by bicinchoninic acid protein assay.
All guanylyl cyclase activity assays were carried out at
37  Ci n5 0 m m Hepes buffer, pH 7.4, containing 50 mm
NaCl, 5% glycerol, 0.05% BSA, 1 mm 3-isobutyl-1-methyl-
xanthine, 2 mm GTP, 30 mm creatine phosphate and
1.5 unitsÆmL
)1 (0.3 units per assay) creatine phosphokinase
[12,17,21,22]. For the stimulation of guanylyl cyclase activ-
ity, crude membranes (10 lg of protein) were incubated
with Mg
2+ GTP and ATP (basal activity), 0.1–100 nm
ANP, ATP and Mg
2+ GTP (stimulated activity) or
Triton X-100 and Mn
2+ GTP (detergent-stimulated activity)
for 10 min [12,17,21,22]. cGMP formation was measured by
RIA [23]. Triton X-100 is known to maximally stimulate the
receptor in a ligand-independent manner [12,17,21,22].
Therefore, the basal and ANP-stimulated cGMP responses
were calculated as a percentage of the maximal Triton-stim-
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branes were controlled by western blotting.
Data analysis
Statistical comparisons were performed using Student’s
t-test (P < 0.05). Data are given as the mean ± SE.
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